tiprankstipranks
Hana Pharm Co., Ltd. (KR:293480)
:293480
South Korea Market

Hana Pharm Co., Ltd. (293480) Financial Statements

Followers

Hana Pharm Co., Ltd. Financial Overview

Hana Pharm Co., Ltd.'s market cap is currently ₩146.35B. The company's EPS TTM is ₩982.93; its P/E ratio is 8.55; and it has a dividend yield of 3.10%. Hana Pharm Co., Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 239.50B₩ 225.34B₩ 224.46B₩ 210.84B₩ 196.41B
Gross Profit₩ 146.39B₩ 141.29B₩ 139.58B₩ 131.24B₩ 130.82B
Operating Income₩ 25.92B₩ 25.15B₩ 27.03B₩ 31.17B₩ 36.01B
EBITDA₩ 36.95B₩ 32.87B₩ 34.68B₩ 37.74B₩ 41.65B
Net Income₩ 8.78B₩ 21.25B₩ 22.33B₩ 24.31B₩ 28.01B
Balance Sheet
Cash & Short-Term Investments₩ 13.47B₩ 12.16B₩ 6.16B₩ 17.58B₩ 56.87B
Total Assets₩ 418.14B₩ 382.01B₩ 348.39B₩ 345.96B₩ 303.50B
Total Debt₩ 58.72B₩ 29.13B₩ 26.53B₩ 34.10B₩ 10.77B
Net Debt₩ 48.88B₩ 20.61B₩ 25.11B₩ 21.55B₩ 4.16B
Total Liabilities₩ 104.73B₩ 72.83B₩ 70.40B₩ 77.57B₩ 51.60B
Stockholders' Equity₩ 313.41B₩ 309.18B₩ 277.98B₩ 268.40B₩ 251.90B
Cash Flow
Free Cash Flow₩ -19.87B₩ 12.09B₩ 3.72B₩ -4.89B₩ -9.16B
Operating Cash Flow₩ 9.18B₩ 25.30B₩ 18.40B₩ 30.88B₩ 25.66B
Investing Cash Flow₩ -29.98B₩ -11.62B₩ -11.89B₩ -36.51B₩ -35.50B
Financing Cash Flow₩ 22.13B₩ -6.81B₩ -17.64B₩ 11.56B₩ -4.09B
Currency in KRW

Hana Pharm Co., Ltd. Earnings and Revenue History

Hana Pharm Co., Ltd. Debt to Assets

Hana Pharm Co., Ltd. Cash Flow

Hana Pharm Co., Ltd. Forecast EPS vs Actual EPS